To combat a fast-evolving global pandemic like COVID-19, it is essential to develop rapid and accurate diagnostic tests with a quick turnaround time. Recently, saliva has emerged as a viable alternate sample source to nasopharyngeal swabs and has shown to have greater detection sensitivity of SARS-CoV-2, as well as consistency throughout the course of infection. Saliva collection is non-invasive, can be self-administered in the convenience of one’s home eliminating the exposure risk to healthcare workers, and reduces the overall burden on swab and personal protective equipment supplies.
DNA Genotek’s OMNIgene.ORAL (OM-505) and ORACollect.RNA (OR-100) collection and stabilization devices are two saliva-based solutions for molecular COVID testing applications, which have been proven to detect and inactivate the SARS-CoV2 virus.
To effectively slow the spread of disease, it is also imperative to have rapid extraction methodologies that can maximize the testing capacity without compromising sensitivity of detection. Omega Bio-tek’s Mag-Bind® Viral RNA Xpress Kit (M6219-2304) answers the speed, scale and high throughput need with its magnetic-bead based approach that can easily be automated on most open-ended liquid handling platforms as well as magnetic processors.
Join DNA Genotek’s Dr. Tara Crawford Parks and Omega Bio-tek’s Dr. Kiranmai Durvasula as they present findings from their recent study verifying the use of saliva collected in OMNIgene.ORAL (OM-505) and ORACollect.RNA (OR-100) in conjunction with viral RNA extraction using Omega Bio-tek’s Mag-Bind® Viral RNA Xpress Kit to enable viral detection via RT-PCR.
At the end of the event, we will hold an open Q&A session. Bring your questions to the webinar or submit them through the registration form below.